Explore the downfall of 23andMe, a once high-valued health tech company, due to their inconsistent business model and flawed health predictions. Discuss the risks of false positives in genetic testing, data security concerns, and challenges of becoming a drug maker. Uncertainty surrounds the company's future.
The lack of accuracy and reliability in 23andMe's ancestry testing and genetic predictions raises doubts about the trustworthiness of the algorithm and its potential negative impact on customers' well-being.
The cybersecurity risks associated with storing vast amounts of DNA data by 23andMe, including the potential creation of targeted biological weapons, highlights the serious impact of cybersecurity issues on the company's reputation and customer trust.
Deep dives
Flaws in ancestry testing and genetic predictions
One of the main problems with 23andMe's business model was the potential flaws in ancestry testing and genetic predictions. An example provided in the podcast mentioned how the DNA results for identical twins from 23andMe showed discrepancies in their ancestry percentages, with one twin having different heritage and ethnicities listed than the other. This indicated a lack of accuracy and reliability in the testing process. Moreover, genetic predictions for health problems were also found to be problematic, with a high risk of false positives. These issues raised doubts about the trustworthiness of the algorithm and the potential negative impact on customers' well-being.
Concerns about cybersecurity and data breaches
Another significant concern discussed in the podcast was the cybersecurity risks associated with the vast amount of DNA data stored by 23andMe. The possibility of stolen DNA information being misused for nefarious purposes, including the creation of targeted biological weapons, raised serious alarms. A previous hack targeting users with Ashkenazi Jewish heritage resulted in a data breach, where the ancestry data of almost 50% of 23andMe's customers was exposed on the dark web. The delayed detection of the breach and the potential implications for ethnic groups highlighted the serious impact of cybersecurity issues on the company's reputation and customer trust.
In today’s episode for 6th February 2024, we explore how a once high-flying health tech company is on the verge of getting chucked out of the NASDAQ index.
If you're a person who is great at communicating and are enthusiastic to join our team, Ditto is looking to recruit new Insurance advisors. You don't even have to know about Insurance, we'll train you from scratch and you can enjoy working remotely with a great team. If you're interested in this or know someone who is please click this link. https://bit.ly/48WX5za
Get the Snipd podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share & Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered podcast player
Listen to all your favourite podcasts with AI-powered features
Discover highlights
Listen to the best highlights from the podcasts you love and dive into the full episode